These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12379830)

  • 1. [Intrauterine devices in general practice: a prospective study of 300 insertions].
    Marret H; Golfier F; Vollerin F; Legoaziou MF; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):465-70. PubMed ID: 12379830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
    Baeyertz JD; Hartfield VJ
    N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications associated with IUD use in a family practice setting.
    Lewis RD; Shank C
    J Fam Pract; 1979 Jan; 8(1):47-52. PubMed ID: 759549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA; Veldhuis HM; Lagro-Janssen TL
    Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The copper T380A intrauterine device in women with type II diabetes mellitus.
    Kjos SL; Ballagh SA; La Cour M; Xiang A; Mishell DR
    Obstet Gynecol; 1994 Dec; 84(6):1006-9. PubMed ID: 7970454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presentation of a new IUD: the "Ombrelle 250"].
    Audebert AJ; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):967-71. PubMed ID: 12267500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decline in popularity of the intrauterine device. A survey of general practitioner attitudes and practices in New South Wales.
    Weisberg E; Fraser IS; Goss S
    Med J Aust; 1994 Jan; 160(1):19-21. PubMed ID: 8271978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multiload CU250 in general practice.
    Gadsby R; Holden J
    Practitioner; 1988 Dec; 232(1460):1343, 1347. PubMed ID: 3256888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices.
    Celen S; Möröy P; Sucak A; Aktulay A; Danişman N
    Contraception; 2004 Apr; 69(4):279-82. PubMed ID: 15033401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiload Cu250 intrauterine devices and VCu200 intrauterine devices for women with previous failure of stainless steel ring intrauterine devices: a 5-year randomized clinical trial].
    Zhang LJ; Weng LJ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):481-3, 511. PubMed ID: 7835121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with the Medusa Cu 240 Ag intrauterine device].
    Girardi F
    Wien Klin Wochenschr; 1993; 105(24):728-31. PubMed ID: 8116311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.